Gartner’s Russell 2500 Growth Reclassification Might Change The Case For Investing In Gartner (IT)

• On 27 June 2026, Gartner, Inc. (NYSE:IT) was added to the Russell 2500 and Russell 2500 Growth Indexes while being removed from the Russell 1000 Growth-Defensive and Russell 1000 Defensive Indexes, reshaping its presence across key US equity benchmarks.
• This index reshuffling can materially affect how passive funds and benchmark-aware investors gain exposure to Gartner, potentially altering trading volumes and investor attention.
• We’ll now examine how Gartner’s shift into the Russell 2500 Growth Index may influence its existing investment narrative and risk profile.

Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Gartner Investment Narrative Recap

To own Gartner, you need to believe its subscription research and advisory model can stay essential even as AI tools and cheaper alternatives multiply. The Russell shift into the 2500 Growth Index mainly changes who holds the stock, not what drives it. The more immediate catalyst and risk still sit in contract value trends and renewal behavior, which the index move does little to directly influence in the short term.

Among recent developments, the March 2026 securities class action over alleged misstatements around contract value growth stands out as most relevant here. While index changes may affect trading flows, the lawsuit cuts closer to the core risk that clients could reassess Gartner’s value, especially as AI and low cost research options expand. How that legal overhang interacts with future CV and renewal data will be critical for the story from here.

Yet against this, investors should be aware that Gartner’s exposure to AI driven disruption could...

Read the full narrative on Gartner (it's free!)

Gartner's narrative projects $7.2 billion revenue and $963.3 million earnings by 2029. This requires 3.7% yearly revenue growth and about a $234 million earnings increase from $729.2 million today.

Uncover how Gartner's forecasts yield a $183.69 fair value, a 35% upside to its current price.

Exploring Other Perspectives

Before this index reshuffle, the most optimistic analysts were modeling revenue around US$7.4 billion and earnings of roughly US$1.1 billion by 2029, which looks far more upbeat than the consensus view and highlights how differently you might weigh risks like AI commoditizing research versus catalysts such as AI enabled productivity gains, especially now that Gartner’s index profile has shifted and those narratives may need revisiting.

Explore 5 other fair value estimates on Gartner - why the stock might be worth just $140.00!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Gartner research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Gartner research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Gartner's overall financial health at a glance.

Interested In Other Possibilities?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• We've uncovered the 7 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com